Although it is not clear if the upregulation of IL-9 in bladder cancer is derived from CLR-mediated dendritic cell activation, we still need to acknowledge that CLR-regulated dendritic cell functions may not always be anti-tumoral, and further research is required to elucidate this issue. Here, DCLK3 is linked to urinary bladder carcinoma.